News

For example, Gocovri, the extended-release capsule, is not approved to prevent or treat influenza type A. How it works Amantadine belongs to a class of drugs called antivirals.
Glenmark Pharmaceuticals recalled 114 batches of potassium chloride extended-release capsules, and American Health Packaging recalled 21 batches of the same capsules last week.
Glenmark Laboratories recalled 114 batches of 750 mg Potassium Chloride Extended-Release Capsules in bottles of 100 (NDC No. 68462-357-01) and 500 (NDC No. 68462-357-05) capsules.
Propafenone hydrochloride capsule, extended release: Upsher-Smith Laboratories discontinued all extended release 225 mg, 325 mg and 425 mg capsules, used in cardiovascular treatments to manage ...
Emrosi ™ (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.. Emrosi, a tetracycline ...
Glenmark Pharmaceuticals Inc. issued a recall for some of its Potassium Chloride Extended-Release Capsules over a "failed dissolution" that may cause heart attacks.
Amneal Pharmaceuticals, Inc. today announced that it has launched CREXONT ® extended-release capsules for the treatment of Parkinson’ s disease. CREXONT is now broadly available at U.S. pharmacies.
Potassium Chloride Extended-Release Capsules are used for the treatment of patients with low potassium (hypokalemia). The capsules are packaged in bottles of 100-count (NDC 68462-357-01) and 500 ...
Hydrocodone extended-release capsules are usually taken once every 12 hours. The extended-release tablet is usually taken once daily. Ask your doctor whether you should take them with or without food.
The FDA released an announcement for a voluntary national recall of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K on Tuesday, June 25th. Glenmark Pharmaceuticals Inc., USA ...
BRIDGEWATER, N.J., September 23, 2024--Amneal Launches CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease ...